Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections
The approval marks a major milestone in the global fight against antimicrobial resistance
The approval marks a major milestone in the global fight against antimicrobial resistance
The company plans to establish similar healthcare centres across universities, schools, and corporate campuses nationwide
The company is building a connected healthcare ecosystem that utilises smart healthcare kiosk and mobile app to deliver at-home, AI-assisted health screenings and non-invasive health measurements
Selected ventures to receive grants and structured intellectual property support to strengthen protection and management of healthcare innovations
The expanded indication is backed by data from the Phase 3 AMPLIFY and GLOW trials and the Phase 2 CAPTIVATE study,
The filing is backed by results from the pivotal SERENA-6 Phase III trial
The study tracked patients for more than five years (median 60.7 months), with protection against disease returning emerging in under four months and continuing long term
Subscribe To Our Newsletter & Stay Updated